Fertility Testing Devices/Fertility Monitoring Devices By Product Type (Ovulation Prediction Kits, Fertility Monitors, And Male Fertility Products), Application (Female Fertility Testing And Male Fertility Testing), End-User (Home Care Settings, Hospitals, And Fertility Clinics), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the rising cases of infertility and the increasing prevalence of polycystic ovary syndrome among women across the globe.
The global fertility testing devices/fertility monitoring devices is estimated to grow at a CAGR of 7.41% during the forecast period from 2023 to 2028. The demand for fertility testing devices/fertility monitoring devices is primarily being boosted due to rising delays in parenthood and the growing prevalence of infertility issues across the globe. Furthermore, lifestyle changes, alcohol consumption, smoking, and others can also increase infertility issues, thereby increasing the demand for fertility testing devices/fertility monitoring devices. Further, the rising cases of miscarriage, the rising adoption of advanced technologies, and the increasing product launches and approval among others are also contributing to the overall growth of fertility testing devices/fertility monitoring devices during the forecast period from 2023-2028.
The data published by the Organization for Economic Co-operation and Development (OECD) 2023 says that in 2021 the total fertility rate (TFR) in Korea, France, Sweden, and Switzerland was 0.81, 1.80, 1.67, and 1.51 respectively which is less than average TFR of 2.1.
As per the above-mentioned source, the TFR for most of the countries in 2020 was below the average TFR with Australia having a TFR of 1.58, Canada at 1.50, China at 1.70, the United States at 1.64, the United Kingdom at 1.56, Spain at 1.36, Japan 1.33, and South Korea with 0.84 TFR.
Infertility issues can be tracked, diagnosed, and managed using ovulation prediction kits, fertility monitors, and other fertility monitoring or testing devices. Thus, the rising figures for infertility will increase the demand for fertility monitoring devices.
Moreover, due to surging exposure to chemicals or radiation, and cigarette smoking, infertility is rising which in turn will increase the demand for fertility monitoring or testing devices.
For instance, according to the OECD Health Statistics 2021, about 20% of women in France, Hungary, Chile, and other nations smoked every day in 2019. As per the same source, in 2019, 5% of women in Indonesia, India, China, Costa Rica, Mexico, and Korea were daily smokers. Smoking can harm a woman's ability to conceive due to hormonal imbalance which can lead to disturbed ovarian function or miscarriage. A fertility monitor can help people understand their menstrual cycle, find their viable window, and increase their chances of conception by tracking ovulation timing, hormone levels, and other reproductive markers. As a result, the use of fertility monitor devices can assist people on their journey to a safe pregnancy. Thus, the need for fertility monitoring devices or fertility testing devices will ultimately grow as people look for resources to improve their reproductive health and boost their chances of getting pregnant.
Coupled with the factors mentioned above, strategic activities such as increasing product launches, approvals, research, and others will also drive the market of fertility testing devices/fertility monitoring devices. For instance, in February 2021, Ava, a digital healthcare company received FDA approval for a fertility tracking sensor bracelet and accompanying app. Ava fertility tracker is the first and only wearable, machine-learning device to aid women in ovulation prediction and facilitation of conception. Thus, the increasing launches and approval will also increase the demand for fertility monitoring devices/fertility testing devices during the forecast period.
Therefore, the above-mentioned factors are contributing to the growth of fertility testing devices/fertility monitoring devices during the forecast period from 2023-2028.
However, cultural and societal stigmas associated with discussing fertility and reproductive health, limited accuracy of fertility testing devices, and others may restrict the demand for fertility testing devices/fertility monitoring devices demand during the forecast year.
In the product segment of the fertility testing devices/fertility monitoring devices, the fertility monitoring sensor segment is expected to amass a significant revenue share in the year 2022 due to several factors such as the increasing demand for non-invasive diagnosis, the increasing technological advancements, the shifting towards home-based monitoring devices, and others.
Additionally, fertility monitors sensor is becoming more and more popular because of technical developments in sensor technology, data processing algorithms, and connection features. These advancements enhance the accuracy, convenience, and overall user experience of the devices, making them more attractive to consumers. Thus, the increasing technological advancement, home-based monitoring devices, and others will increase the demand for fertility monitor sensors during the forecast period.
The surging product launches and approvals will also create a positive impact on the demand for fertility monitoring sensors during the forecast period from 2023-2028. For instance, in June 2021, Fertility Focus launched the ovufirst skin-worn sensor to add support for women starting on their journey to pregnancy. Thus, the increasing product launches and approval among others may also increase the demand for fertility monitoring sensor devices.
Therefore, the advantages offered by fertility monitoring sensors, product launches, and approval among others are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall fertility testing devices/fertility monitoring devices during the forecast period.
Infertility affects around 1 in 5 married women in the United States between the ages of 15 and 49 who have never given birth, according to statistics from the Centres for Disease Control and Prevention (CDC) from the year 2023.
Additionally, as per the same source, 26% of women have impaired fecundity, which affects their ability to become pregnant or carry a pregnancy to term. After a year of trying, around 6% of married women between the ages of 15 and 49 are unable to conceive, and 14% have trouble becoming pregnant or bringing a pregnancy to term.
Further, there are not many incidences of infertility in nations like Canada. The country's fertility rate fell from 1.47 children per woman in 2022, according to Statistics Canada. Overall, infertility increases the demand for fertility monitoring devices as they help identify fertile windows and times of intercourse accurately and provide valuable data for diagnosis, treatment planning, and improving chances of conception.
Thus, the advantages of fertility monitoring devices/fertility testing devices to track menstrual cycles, and support lifestyle adjustments to enhance fertility will increase the demand for fertility monitoring devices/fertility testing devices in the North American region during the forecast period.
Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in 2020, Bengaluru (India) based medical technology startup Inito announced that its fertility monitor had cleared the regulatory pathway of the United States Food and Drug Administration (FDA). Thus, such strategic steps help to increase the demand for fertility testing devices/fertility monitoring devices. Thereby, driving the North America fertility testing devices/fertility monitoring devices forward during the forecast period from 2023-2028.
This product will be delivered within 2 business days.
The global fertility testing devices/fertility monitoring devices is estimated to grow at a CAGR of 7.41% during the forecast period from 2023 to 2028. The demand for fertility testing devices/fertility monitoring devices is primarily being boosted due to rising delays in parenthood and the growing prevalence of infertility issues across the globe. Furthermore, lifestyle changes, alcohol consumption, smoking, and others can also increase infertility issues, thereby increasing the demand for fertility testing devices/fertility monitoring devices. Further, the rising cases of miscarriage, the rising adoption of advanced technologies, and the increasing product launches and approval among others are also contributing to the overall growth of fertility testing devices/fertility monitoring devices during the forecast period from 2023-2028.
Fertility Testing Devices/Fertility Monitoring Devices Dynamics:
Fertility testing devices/fertility monitoring devices are witnessing a positive growth in product demand owing to various factors, one of the key factors is the rising number of infertility cases.The data published by the Organization for Economic Co-operation and Development (OECD) 2023 says that in 2021 the total fertility rate (TFR) in Korea, France, Sweden, and Switzerland was 0.81, 1.80, 1.67, and 1.51 respectively which is less than average TFR of 2.1.
As per the above-mentioned source, the TFR for most of the countries in 2020 was below the average TFR with Australia having a TFR of 1.58, Canada at 1.50, China at 1.70, the United States at 1.64, the United Kingdom at 1.56, Spain at 1.36, Japan 1.33, and South Korea with 0.84 TFR.
Infertility issues can be tracked, diagnosed, and managed using ovulation prediction kits, fertility monitors, and other fertility monitoring or testing devices. Thus, the rising figures for infertility will increase the demand for fertility monitoring devices.
Moreover, due to surging exposure to chemicals or radiation, and cigarette smoking, infertility is rising which in turn will increase the demand for fertility monitoring or testing devices.
For instance, according to the OECD Health Statistics 2021, about 20% of women in France, Hungary, Chile, and other nations smoked every day in 2019. As per the same source, in 2019, 5% of women in Indonesia, India, China, Costa Rica, Mexico, and Korea were daily smokers. Smoking can harm a woman's ability to conceive due to hormonal imbalance which can lead to disturbed ovarian function or miscarriage. A fertility monitor can help people understand their menstrual cycle, find their viable window, and increase their chances of conception by tracking ovulation timing, hormone levels, and other reproductive markers. As a result, the use of fertility monitor devices can assist people on their journey to a safe pregnancy. Thus, the need for fertility monitoring devices or fertility testing devices will ultimately grow as people look for resources to improve their reproductive health and boost their chances of getting pregnant.
Coupled with the factors mentioned above, strategic activities such as increasing product launches, approvals, research, and others will also drive the market of fertility testing devices/fertility monitoring devices. For instance, in February 2021, Ava, a digital healthcare company received FDA approval for a fertility tracking sensor bracelet and accompanying app. Ava fertility tracker is the first and only wearable, machine-learning device to aid women in ovulation prediction and facilitation of conception. Thus, the increasing launches and approval will also increase the demand for fertility monitoring devices/fertility testing devices during the forecast period.
Therefore, the above-mentioned factors are contributing to the growth of fertility testing devices/fertility monitoring devices during the forecast period from 2023-2028.
However, cultural and societal stigmas associated with discussing fertility and reproductive health, limited accuracy of fertility testing devices, and others may restrict the demand for fertility testing devices/fertility monitoring devices demand during the forecast year.
Fertility Testing Devices/Fertility Monitoring Devices Segment Analysis:
Fertility Testing Devices/Fertility Monitoring Devices by Product Type (Ovulation Prediction Kits, Fertility Monitors Sensor, and Male Fertility Products), Application (Female Fertility Testing and Male Fertility Testing), End-User (Home Care Settings, Hospitals, and Fertility Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).In the product segment of the fertility testing devices/fertility monitoring devices, the fertility monitoring sensor segment is expected to amass a significant revenue share in the year 2022 due to several factors such as the increasing demand for non-invasive diagnosis, the increasing technological advancements, the shifting towards home-based monitoring devices, and others.
Additionally, fertility monitors sensor is becoming more and more popular because of technical developments in sensor technology, data processing algorithms, and connection features. These advancements enhance the accuracy, convenience, and overall user experience of the devices, making them more attractive to consumers. Thus, the increasing technological advancement, home-based monitoring devices, and others will increase the demand for fertility monitor sensors during the forecast period.
The surging product launches and approvals will also create a positive impact on the demand for fertility monitoring sensors during the forecast period from 2023-2028. For instance, in June 2021, Fertility Focus launched the ovufirst skin-worn sensor to add support for women starting on their journey to pregnancy. Thus, the increasing product launches and approval among others may also increase the demand for fertility monitoring sensor devices.
Therefore, the advantages offered by fertility monitoring sensors, product launches, and approval among others are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall fertility testing devices/fertility monitoring devices during the forecast period.
North America is expected to dominate the overall Fertility Testing Devices/Fertility Monitoring Devices:
Among all the regions, North America is estimated to account for the largest share of fertility testing devices/fertility monitoring devices in the year 2022. This domination is owing to key growth factors such as the rising prevalence of infertility in the region and the increasing awareness about fertility monitoring devices. Furthermore, increasing healthcare expenditure, rising research and development activities, regulatory approval for new devices, and increasing technological advancement will also help the market growth in this region.Infertility affects around 1 in 5 married women in the United States between the ages of 15 and 49 who have never given birth, according to statistics from the Centres for Disease Control and Prevention (CDC) from the year 2023.
Additionally, as per the same source, 26% of women have impaired fecundity, which affects their ability to become pregnant or carry a pregnancy to term. After a year of trying, around 6% of married women between the ages of 15 and 49 are unable to conceive, and 14% have trouble becoming pregnant or bringing a pregnancy to term.
Further, there are not many incidences of infertility in nations like Canada. The country's fertility rate fell from 1.47 children per woman in 2022, according to Statistics Canada. Overall, infertility increases the demand for fertility monitoring devices as they help identify fertile windows and times of intercourse accurately and provide valuable data for diagnosis, treatment planning, and improving chances of conception.
Thus, the advantages of fertility monitoring devices/fertility testing devices to track menstrual cycles, and support lifestyle adjustments to enhance fertility will increase the demand for fertility monitoring devices/fertility testing devices in the North American region during the forecast period.
Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in 2020, Bengaluru (India) based medical technology startup Inito announced that its fertility monitor had cleared the regulatory pathway of the United States Food and Drug Administration (FDA). Thus, such strategic steps help to increase the demand for fertility testing devices/fertility monitoring devices. Thereby, driving the North America fertility testing devices/fertility monitoring devices forward during the forecast period from 2023-2028.
Fertility Testing Devices/Fertility Monitoring Devices Key Players:
Some of the key market players operating in the fertility testing devices/fertility monitoring devices include Church & Dwight Co., Inc., Geratherm Medical AG, viO HealthTech Limited, FERTILITY FOCUS LIMITED, Fairhaven Health, Quidel, ro, Abbott, Swiss Precision Diagnostics GmbH, Mira, Tempdrop, Samplytics Technologies Private Limited, Lady Technologies, Inc., Valley Electronics AG, Alfa Scientific Designs, Inc, FemTec Health, Babystart, bioZhena Corporation, Eli, INNE, Femometer, and others.Recent Developmental Activities in the Fertility Testing Devices/Fertility Monitoring Devices:
- In February 2021, OvuSense announced a partnership with ExSeed, a provider of a complete monitoring solution for a couple who is trying to conceive. Together they offer best-in-class clinically proven medical monitoring, allowing couples to share data and work with their specialists remotely while monitoring their fertility health at home.
- In May 2021, Ro, a digital elective care and telemedicine provider announced that it had acquired modern fertility, a reproductive health company founded in 2017.
Key Takeaways from the Fertility Testing Devices/Fertility Monitoring Devices Report Study
- Market size analysis for current fertility testing devices/fertility monitoring devices size (2022), and market forecast for 5 years (2023-2028)
- Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
- Key companies dominating the global fertility testing devices/fertility monitoring devices.
- Various opportunities are available for the other competitors in the fertility testing devices/fertility monitoring devices space.
- What are the top-performing segments in 2022? How these segments will perform in 2028.
- Which are the top-performing regions and countries in the current fertility testing devices/fertility monitoring devices scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for fertility testing devices/fertility monitoring devices growth in the coming future?
Target Audience who can be benefited from this Fertility Testing Devices/Fertility Monitoring Devices Report Study
- Fertility testing devices/fertility monitoring devices products providers
- Research organizations and consulting companies
- Fertility testing devices/fertility monitoring devices-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders dealing in the fertility testing devices/fertility monitoring devices
- Various End-users who want to know more about fertility testing devices/fertility monitoring devices and the latest technological developments in fertility testing devices/fertility monitoring devices.
Frequently Asked Questions for the Fertility Testing Devices/Fertility Monitoring Devices:
1. What are fertility testing devices/fertility monitoring devices?
Fertility testing devices or fertility monitoring devices, are devices and kits that help individuals track and monitor reproductive health. They provide information about menstrual cycles, ovulation, and hormone levels and aid in family planning and optimizing conception timing.2. What is the market for global fertility testing devices/fertility monitoring devices?
The global fertility testing devices/fertility monitoring devices is estimated to grow at a CAGR of 7.41% during the forecast period from 2023 to 2028.3. What are the drivers for global fertility testing devices/fertility monitoring devices?
The demand for fertility testing devices/fertility monitoring devices is primarily being heightened by the rising prevalence of infertility. Further, the rising awareness and a proactive approach to reproductive health which help to monitor and understand their fertility, the increasing technological advancement, the rising adoption of advanced and innovative technologies, the increasing product launches & approval, and among others thereby contribute to the overall growth of fertility testing devices/fertility monitoring devices during the forecast period from 2023-2028.4. Who are the key players operating in the global fertility testing devices/fertility monitoring devices?
Some of the key market players operating in the fertility testing devices/fertility monitoring devices include Church & Dwight Co., Inc., Geratherm Medical AG, viO HealthTech Limited, FERTILITY FOCUS LIMITED, Fairhaven Health, Quidel, ro, Abbott, Swiss Precision Diagnostics GmbH, Mira, Tempdrop, Samplytics Technologies Private Limited, Lady Technologies, Inc., Valley Electronics AG, Alfa Scientific Designs, Inc, FemTec Health, Babystart, bioZhena Corporation, Eli, INNE, Femometer, and others.5. Which region has the highest share of fertility testing devices/fertility monitoring devices?
North America is expected to dominate the overall fertility testing devices/fertility monitoring devices during the forecast period from 2023-2028. The demand for fertility testing devices/fertility monitoring devices is increasing in the North America region due to some factors such as the higher prevalence of infertility issues, increasing investments in research and development, and others. Additionally, the North American region has a well-established healthcare infrastructure, high awareness about reproductive health, and greater accessibility to advanced medical technologies which will increase the demand for fertility testing devices/fertility monitoring devices in this region.This product will be delivered within 2 business days.
Table of Contents
1. Fertility Testing Devices/Fertility Monitoring Devices Report Introduction2. Fertility Testing Devices/Fertility Monitoring Devices Executive Summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
3. Regulatory Analysis
3.1. The United States
3.2. Europe
3.3. Japan
3.4. China
4. Fertility Testing Devices/Fertility Monitoring Devices Key Factors Analysis
4.1. Fertility Testing Devices/Fertility Monitoring Devices Drivers
4.1.1. Increasing prevalence of infertility issues
4.1.2. Growing awareness and acceptance of fertility tracking methods
4.1.3. Advancements in technology, provide more accurate and user-friendly monitoring devices
4.2. Fertility Testing Devices/Fertility Monitoring Devices Restraints and Challenges
4.2.1. Cultural and societal stigmas associated with discussing fertility and reproductive health
4.2.2. Limited accuracy of fertility testing devices
4.3. Fertility Testing Devices/Fertility Monitoring Devices Opportunities
4.3.1. Integration of fertility tracking technology with smartphones and wearable devices, enhancing convenience and user experience
5. Fertility Testing Devices/Fertility Monitoring Devices Porter’s Five Forces Analysis
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. The Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. Fertility Testing Devices/Fertility Monitoring Devices Layout
6.1. By Product Type
6.1.1. Ovulation Prediction Kits
6.1.2. Fertility Monitors
6.1.3. Male Fertility Products
6.2. By Application
6.2.1. Female Fertility Testing
6.2.2. Male Fertility Testing
6.3. By End-User
6.3.1. Home Care Settings
6.3.2. Hospitals
6.3.3. Fertility Clinics
6.4. By Geography
6.4.1. North America Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.1.1. United States Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.1.2. Canada Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.1.3. Mexico Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.2. Europe Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.2.1. France Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.2.2. Germany Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.2.3. United Kingdom Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.2.4. Italy Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.2.5. Spain Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.2.6. Rest of Europe Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.3. Asia-Pacific Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.3.1. China Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.3.2. Japan Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.3.3. India Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.3.4. Australia Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.3.5. South Korea Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.3.6. Rest of Asia-Pacific Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.4. Rest of the World (RoW) Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.4.1. Middle East Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.4.2. Africa Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
6.4.4.3. South America Fertility Testing Devices/Fertility Monitoring Devices Size in USD million (2020-2028)
7. Fertility Testing Devices/Fertility Monitoring Devices Company and Product Profiles
7.1. Fairhaven Health
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Financial Overview
7.1.4. Product Listing
7.1.5. Entropy
7.2. Geratherm Medical AG
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Financial Overview
7.2.4. Product Listing
7.2.5. Entropy
7.3. FERTILITY FOCUS LIMITED
7.3.1. Company Snapshot
7.3.2. Financial Overview
7.3.3. Product Listing
7.3.4. Entropy
7.4. ro
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Financial Overview
7.4.4. Product Listing
7.4.5. Entropy
7.5. Quidel
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Financial Overview
7.5.4. Product Listing
7.5.5. Entropy
7.6. Church & Dwight Co., Inc
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Financial Overview
7.6.4. Product Listing
7.6.5. Entropy
7.7. Abbott
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Financial Overview
7.7.4. Product Listing
7.7.5. Entropy
7.8. Swiss Precision Diagnostics GmbH
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Financial Overview
7.8.4. Product Listing
7.8.5. Entropy
7.9. viO HealthTech Limited
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Financial Overview
7.9.4. Product Listing
7.9.5. Entropy
7.10. Mira
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Financial Overview
7.10.4. Product Listing
7.10.5. Entropy
7.11. Tempdrop
7.11.1. Company Overview
7.11.2. Company Snapshot
7.11.3. Financial Overview
7.11.4. Product Listing
7.11.5. Entropy
7.12. Samplytics Technologies Private Limited
7.12.1. Company Overview
7.12.2. Company Snapshot
7.12.3. Financial Overview
7.12.4. Product Listing
7.12.5. Entropy
7.13. Lady Technologies, Inc.
7.13.1. Company Overview
7.13.2. Company Snapshot
7.13.3. Financial Overview
7.13.4. Product Listing
7.13.5. Entropy
7.14. Valley Electronics AG
7.14.1. Company Overview
7.14.2. Company Snapshot
7.14.3. Financial Overview
7.14.4. Product Listing
7.14.5. Entropy
7.15. Alfa Scientific Designs, Inc
7.15.1. Company Overview
7.15.2. Company Snapshot
7.15.3. Financial Overview
7.15.4. Product Listing
7.15.5. Entropy
7.16. FemTec Health
7.16.1. Company Overview
7.16.2. Company Snapshot
7.16.3. Financial Overview
7.16.4. Product Listing
7.16.5. Entropy
7.17. Babystart
7.17.1. Company Overview
7.17.2. Company Snapshot
7.17.3. Financial Overview
7.17.4. Product Listing
7.17.5. Entropy
7.18. bioZhena Corporation
7.18.1. Company Overview
7.18.2. Company Snapshot
7.18.3. Financial Overview
7.18.4. Product Listing
7.18.5. Entropy
7.19. Eli
7.19.1. Company Overview
7.19.2. Company Snapshot
7.19.3. Financial Overview
7.19.4. Product Listing
7.19.5. Entropy
7.20. INNE
7.20.1. Company Overview
7.20.2. Company Snapshot
7.20.3. Financial Overview
7.20.4. Product Listing
7.20.5. Entropy
7.21. Femometer
7.21.1. Company Overview
7.21.2. Company Snapshot
7.21.3. Financial Overview
7.21.4. Product Listing
7.21.5. Entropy
8. KOL Views
9. Project Approach
10. About DelveInsight
11. Disclaimer & Contact Us
List of Tables
Table 1: Competitive Analysis
Table 2: Fertility Testing Devices/Fertility Monitoring Devices in Global (2020-2028)
Table 3: Fertility Testing Devices/Fertility Monitoring Devices in Global by Product Type (2020-2028)
Table 4: Fertility Testing Devices/Fertility Monitoring Devices in Global by Application (2020-2028)
Table 5: Fertility Testing Devices/Fertility Monitoring Devices in Global by End-User (2020-2028)
Table 6: Fertility Testing Devices/Fertility Monitoring Devices in Global by Geography (2020-2028)
Table 7: Fertility Testing Devices/Fertility Monitoring Devices in North America (2020-2028)
Table 8: Fertility Testing Devices/Fertility Monitoring Devices in the US (2020-2028)
Table 9: Fertility Testing Devices/Fertility Monitoring Devices in Canada (2020-2028)
Table 10: Fertility Testing Devices/Fertility Monitoring Devices in Mexico (2020-2028)
Table 11: Fertility Testing Devices/Fertility Monitoring Devices in Europe (2020-2028)
Table 12: Fertility Testing Devices/Fertility Monitoring Devices in France (2020-2028)
Table 13: Fertility Testing Devices/Fertility Monitoring Devices in Germany (2020-2028)
Table 14: Fertility Testing Devices/Fertility Monitoring Devices in the United Kingdom (2020-2028)
Table 15: Fertility Testing Devices/Fertility Monitoring Devices in Italy (2020-2028)
Table 16: Fertility Testing Devices/Fertility Monitoring Devices in Spain (2020-2028)
Table 17: Fertility Testing Devices/Fertility Monitoring Devices in the Rest of Europe (2020-2028)
Table 18: Fertility Testing Devices/Fertility Monitoring Devices in Asia-Pacific (2020-2028)
Table 19: Fertility Testing Devices/Fertility Monitoring Devices in China (2020-2028)
Table 20: Fertility Testing Devices/Fertility Monitoring Devices in Japan (2020-2028)
Table 21: Fertility Testing Devices/Fertility Monitoring Devices in India (2020-2028)
Table 22: Fertility Testing Devices/Fertility Monitoring Devices in Australia (2020-2028)
Table 23: Fertility Testing Devices/Fertility Monitoring Devices in South Korea (2020-2028)
Table 24: Fertility Testing Devices/Fertility Monitoring Devices in the Rest of Asia-Pacific (2020-2028)
Table 25: Fertility Testing Devices/Fertility Monitoring Devices in the Middle East (2020-2028)
Table 26: Fertility Testing Devices/Fertility Monitoring Devices in Africa (2020-2028)
Table 27: Fertility Testing Devices/Fertility Monitoring Devices in South America (2020-2028)
List of Figures
Figure 1: Competitive Analysis
Figure 2: Fertility Testing Devices/Fertility Monitoring Devices in Global (2020-2028)
Figure 3: Fertility Testing Devices/Fertility Monitoring Devices in Global by Product Type (2020-2028)
Figure 4: Fertility Testing Devices/Fertility Monitoring Devices in Global by Application (2020-2028)
Figure 5: Fertility Testing Devices/Fertility Monitoring Devices in Global by End-User (2020-2028)
Figure 6: Fertility Testing Devices/Fertility Monitoring Devices in Global by Geography (2020-2028)
Figure 7: Fertility Testing Devices/Fertility Monitoring Devices in North America (2020-2028)
Figure 8: Fertility Testing Devices/Fertility Monitoring Devices in the US (2020-2028)
Figure 9: Fertility Testing Devices/Fertility Monitoring Devices in Canada (2020-2028)
Figure 10: Fertility Testing Devices/Fertility Monitoring Devices in Mexico (2020-2028)
Figure 11: Fertility Testing Devices/Fertility Monitoring Devices in Europe (2020-2028)
Figure 12: Fertility Testing Devices/Fertility Monitoring Devices in France (2020-2028)
Figure 13: Fertility Testing Devices/Fertility Monitoring Devices in Germany (2020-2028)
Figure 14: Fertility Testing Devices/Fertility Monitoring Devices in the United Kingdom (2020-2028)
Figure 15: Fertility Testing Devices/Fertility Monitoring Devices in Italy (2020-2028)
Figure 16: Fertility Testing Devices/Fertility Monitoring Devices in Spain (2020-2028)
Figure 17: Fertility Testing Devices/Fertility Monitoring Devices in the Rest of Europe (2020-2028)
Figure 18: Fertility Testing Devices/Fertility Monitoring Devices in Asia-Pacific (2020-2028)
Figure 19: Fertility Testing Devices/Fertility Monitoring Devices in China (2020-2028)
Figure 20: Fertility Testing Devices/Fertility Monitoring Devices in Japan (2020-2028)
Figure 21: Fertility Testing Devices/Fertility Monitoring Devices in India (2020-2028)
Figure 22: Fertility Testing Devices/Fertility Monitoring Devices in Australia (2020-2028)
Figure 23: Fertility Testing Devices/Fertility Monitoring Devices in South Korea (2020-2028)
Figure 24: Fertility Testing Devices/Fertility Monitoring Devices in the Rest of Asia-Pacific (2020-2028)
Figure 25: Fertility Testing Devices/Fertility Monitoring Devices in the Middle East (2020-2028)
Figure 26: Fertility Testing Devices/Fertility Monitoring Devices in Africa (2020-2028)
Figure 27: Fertility Testing Devices/Fertility Monitoring Devices in South America (2020-2028)
Figure 28: PORTER'S Five Force Analysis
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Church & Dwight Co., Inc.
- Geratherm Medical AG
- viO HealthTech Limited
- FERTILITY FOCUS LIMITED
- Fairhaven Health
- Quidel, ro
- Abbott
- Swiss Precision Diagnostics GmbH
- Mira
- Tempdrop
- Samplytics Technologies Private Limited
- Lady Technologies, Inc.
- Valley Electronics AG
- Alfa Scientific Designs, Inc
- FemTec Health
- Babystart
- bioZhena Corporation
- Eli
- INNE
- Femometer
